查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2135580

柱式寡核苷酸合成設備市場：全球市場預測，2026-2032年

Column Oligonucleotide Synthesizers Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，柱式寡核苷酸合成設備市場將成長至 19.7 億美元，複合年成長率為 9.58%。

主要市場統計數據
基準年 2025 10.4億美元
預計年份：2026年 11.2億美元
預測年份 2032 19.7億美元
複合年成長率 (%) 9.58%

柱狀寡核苷酸合成儀：執行摘要

柱式寡核苷酸合成儀是一種自動化平台，用於在撐體上組裝短的、客製化的核酸序列。它們廣泛應用於分子診斷、科學研究、定序流程、藥物開發和合成生物學等領域。市場需求主要來自可重複合成、靈活的批次大小控制、污染控制、工作流程整合以及可靠的試劑和服務供應等要求。

自動化和工作流程整合正在改變合成的方式。

市場環境正從獨立式儀器轉向整合式、軟體控制的工作流程。使用者越來越重視試劑的自動化處理、平行處理、可追溯性、快速方法設定以及與下游純化和品管流程的兼容性。維護需求、操作人員訓練、廢棄物管理以及處理各種化學反應和序列格式的能力也會影響儀器的選擇。

人工智慧可以提升設計、進度安排和品管。

人工智慧 (AI) 可透過輔助序列設計、流程調度、異常檢測、預測性維護和分析資料解讀來改進寡核苷酸合成。其實際價值取決於管理良好的資料集、檢驗的模型、安全的實驗室連接以及手動審核。當人工智慧工具能夠提供可解釋的建議並與現有的品管系統保持整合，而不是取代實驗室監管時，其應用最為可靠。

區域洞察：產能、法規與基礎設施推動普及

在北美，強大的生物醫學研究能力與對靈活、自動化實驗室平台的需求相輔相成；而在歐洲，監管合規、永續性、可追溯性和合作研究基礎設施是關鍵考慮因素。亞太地區受惠於不斷擴大的生物技術活動、製造能力和基因組學投資，但不同市場的准入條件各不相同。拉丁美洲的發展主要體現在學術、診斷和製藥領域的應用，但採購往往會受到服務支援和進口物流的影響。中東正在建立先進的生命科學和醫療保健能力，而非洲則在公共衛生檢查室、研究網路和本地能力建設方面提供了機會。這兩個地區都可能面臨基礎設施、專業知識和供應連續性的限制。

團體洞察：經濟與安全聯盟塑造採購環境

東協市場在檢查室成熟度方面存在差異，但受益於製造業、研究和醫療保健領域的區域合作。金磚國家擁有重要的研發和生產環境，但在監管、基礎設施和專業投入品取得方面存在顯著差異。歐盟高度重視統一標準、資料管治、永續性和跨境研究。七國集團（G7）國家普遍對自動化、品質保證和高通量分子工作流程有成熟的需求。海灣合作理事會（GCC）國家正在加大對醫療保健和生物技術能力現代化的投資，而北約成員國通常將先進的研究生態系統與對韌性、安全數據處理和可靠供應鏈的要求相結合。

各國概況：每個國家的研究體係都有其獨特的優先事項。

澳洲支持跨地域機構進行基因組學、臨床研究和轉化科學研究。巴西和墨西哥看到了診斷、公共衛生研究和生物技術開發的機遇，但採購受到基礎設施和進口因素的影響。加拿大、美國、法國、德國、義大利、西班牙和英國已建立起以自動化、合規性、互通性和快速服務響應為重點的研究和醫療生態系統。中國和印度在不斷發展的生物技術活動與巨大的國內研究需求之間取得了平衡，而日本和韓國則強調精準性、先進製造和高品質的實驗室運作。俄羅斯的科學研究環境受其研究能力、在地化優先事項以及獲取國際設備和耗材的管道等因素的影響。

寡核苷酸合成領域領導者應優先考慮的問題

領導者應根據​​檢驗的應用需求來確定儀器配置，而不是僅僅追求處理能力。優先事項應包括模組化自動化、開放且可審計的軟體、強大的污染防治、試劑可追溯性、現場技術支援以及清晰的維護計劃。各機構應建立合格規程，監控產量和誤差相關指標，並評估涵蓋耗材、廢棄物、人事費用和停機時間的整體營運需求。與研究機構和工作流程整合專家建立合作關係可以加快部署速度，但網路安全、資料管治和業務永續營運計畫應從一開始就納入考量。

調查方法：對所提供的市場範圍進行系統性解讀。

本執行摘要闡述了所提供柱式寡核苷酸合成設備的市場範圍，並考慮了既有應用、技術、法規、基礎設施和地理因素。它整合了定性和數據支援的行業市場促進因素，但未提供市場估算、預測、佔有率數據或任何公司的具體聲明。區域、群體和國家層級的觀察結果反映了研究能力、醫療發展、採購條件和實驗室基礎設施的差異。投資決策應檢驗目前的監管、貿易和機構資訊來源。

結論：可靠的自動化和本地化適應性決定策略優勢。

柱式寡核苷酸合成儀仍然是現代分子研究、診斷和治療工作流程中至關重要的基礎工具。競爭優勢日益取決於可重複性、自動化程度、整合分析能力、軟體品質、服務支援以及可靠的試劑和專業知識獲取管道。那些將檢驗的流程與負責任的人工智慧應用、健全的品管體係以及區域性部署計畫相結合的機構，將更有能力有效且永續地利用其合成能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 柱式寡核苷酸合成設備市場：依產品類型分類

  • 用於分析
    • 微血管
    • 高效液相層析整合
  • 用於製備性分離
    • 大規模
    • 中號

第8章 柱式寡核苷酸合成設備市場：依合成化學分類

  • 液相
    • 化學連接
    • 酵素合成
  • 固相法
    • H-膦酸酯法
    • 亞磷醯胺法

第9章：柱式寡核苷酸合成設備市場：依通量分類

  • 高通量
    • 自動化系統
    • 半自動系統
  • 低吞吐量

第10章：柱式寡核苷酸合成設備市場：依尺寸分類

  • 長鏈
  • 中長鏈
  • 短鏈

第11章 柱式寡核苷酸合成設備市場：依應用領域分類

  • 農業生物技術
    • 動物健康
    • 作物改良
  • 診斷調查
    • 生物標記檢測
    • 基因檢測套組
  • 基因組調查
    • PCR探針
    • 定序探針
  • 藥物研發
    • 反義寡核苷酸
    • siRNA合成

第12章 柱式寡核苷酸合成設備市場：依最終用戶分類

  • 生物製藥公司
    • 大型製藥企業
    • 中小型生技公司
  • 受託研究機構
    • 發展服務
    • 發現服務
  • 診斷檢查室
  • 研究機構

第13章 柱式寡核苷酸合成設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 柱式寡核苷酸合成設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 柱式寡核苷酸合成設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Agilent Technologies, Inc.
  • Ajinomoto Bio-Pharma Services
  • Azenta US Inc.
  • BioAutomation Corporation
  • Biolytic Lab Performance Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Integrated DNA Technologies
  • Kaneka Eurogentec SA
  • LGC Biosearch Technologies
  • Merck KGaA
  • Nitto Denko Avecia Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies LLC
  • Twist Bioscience Corporation

第18章 主要專家

Product Code: MRR-961F26FD64E5

The Column Oligonucleotide Synthesizers Market is projected to grow by USD 1.97 billion at a CAGR of 9.58% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.04 billion
Estimated Year [2026] USD 1.12 billion
Forecast Year [2032] USD 1.97 billion
CAGR (%) 9.58%

Column Oligonucleotide Synthesizers: Executive Summary

Column oligonucleotide synthesizers are automated platforms used to assemble short, custom nucleic-acid sequences on solid supports. They support applications including molecular diagnostics, research, sequencing workflows, therapeutic development, and synthetic biology. Demand is shaped by the need for reproducible synthesis, flexible batch sizes, contamination control, workflow integration, and dependable reagent and service availability.

Automation and Workflow Integration Are Reshaping Synthesis

The landscape is shifting from stand-alone instruments toward integrated, software-directed workflows. Users increasingly prioritize automated reagent handling, parallel processing, traceability, rapid method setup, and compatibility with downstream purification and quality-control steps. Instrument selection is also being influenced by maintenance requirements, operator training, waste management, and the ability to accommodate diverse chemistries and sequence formats.

Artificial Intelligence Strengthens Design, Scheduling, and Quality Control

Artificial intelligence can improve oligonucleotide synthesis by supporting sequence design, process scheduling, anomaly detection, predictive maintenance, and interpretation of analytical data. Its practical value depends on well-curated datasets, validated models, secure laboratory connectivity, and human review. Adoption is most credible where AI tools provide explainable recommendations and remain integrated with established quality systems rather than replacing laboratory oversight.

Regional Insights: Capacity, Regulation, and Infrastructure Drive Adoption

North America combines strong biomedical research capacity with demand for flexible, automated laboratory platforms. Europe emphasizes regulatory alignment, sustainability, traceability, and collaborative research infrastructure. Asia-Pacific is supported by expanding biotechnology activity, manufacturing capabilities, and investments in genomics, although implementation conditions vary across markets. Latin America is developing through academic, diagnostic, and pharmaceutical applications, with procurement often influenced by service support and import logistics. The Middle East is building advanced life-science and healthcare capabilities, while Africa shows opportunity linked to public-health laboratories, research networks, and local capacity development; both regions may face constraints involving infrastructure, specialized skills, and supply continuity.

Group Insights: Economic and Security Alliances Shape Procurement Context

ASEAN markets reflect varied levels of laboratory maturity and benefit from regional manufacturing, research, and healthcare connectivity. BRICS members span major research and production environments but differ substantially in regulation, infrastructure, and access to specialized inputs. The European Union places strong emphasis on harmonized standards, data governance, sustainability, and cross-border research. G7 markets generally show mature demand for automation, quality assurance, and high-throughput molecular workflows. GCC countries are investing in healthcare modernization and biotechnology capacity, while NATO members often pair advanced research ecosystems with requirements related to resilience, secure data handling, and dependable supply chains.

Country Insights: National Research Systems Create Distinct Priorities

Australia supports genomics, clinical research, and translational science across geographically dispersed institutions. Brazil and Mexico present opportunities connected to diagnostics, public-health research, and biotechnology development, with procurement affected by infrastructure and import considerations. Canada, the United States, France, Germany, Italy, Spain, and the United Kingdom have established research and healthcare ecosystems that value automation, compliance, interoperability, and service responsiveness. China and India combine expanding biotechnology activity with substantial domestic research needs, while Japan and South Korea emphasize precision, advanced manufacturing, and high-quality laboratory operations. Russia's environment is shaped by research capability, localization priorities, and access to international equipment and consumables.

Action Priorities for Leaders in Oligonucleotide Synthesis

Leaders should match instrument configuration to validated application requirements rather than pursuing capacity alone. Priorities include modular automation, open and auditable software, robust contamination controls, reagent traceability, local technical support, and clear maintenance planning. Organizations should establish qualification protocols, monitor yield and error-related indicators, and evaluate total operating requirements across consumables, waste, labor, and downtime. Partnerships with research institutions and workflow-integration specialists can accelerate adoption, while cybersecurity, data governance, and continuity planning should be incorporated from the start.

Methodology: Structured Interpretation of the Supplied Market Scope

This executive summary interprets the supplied market scope for column oligonucleotide synthesizers using established application, technology, regulatory, infrastructure, and geographic considerations. It synthesizes qualitative, data-backed industry drivers without presenting market estimates, shares, forecasts, or company-specific claims. Regional, group, and country observations are framed as contextual differences in research capacity, healthcare development, procurement conditions, and laboratory infrastructure; they should be validated against current regulatory, trade, and institutional sources before investment decisions.

Conclusion: Reliable Automation and Regional Fit Define Strategic Advantage

Column oligonucleotide synthesizers remain important enabling tools for modern molecular research, diagnostics, and therapeutic workflows. Competitive differentiation increasingly depends on reproducibility, automation, analytical integration, software quality, service support, and resilient access to reagents and expertise. Organizations that combine validated processes with responsible AI adoption, strong quality systems, and region-specific implementation planning will be better positioned to use synthesis capacity effectively and sustainably.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Column Oligonucleotide Synthesizers Market, by Product Type

  • 7.1. Introduction
  • 7.2. Analytical
    • 7.2.1. Capillary
    • 7.2.2. HPLC Integrated
  • 7.3. Preparative
    • 7.3.1. Large Scale
    • 7.3.2. Medium Scale

8. Column Oligonucleotide Synthesizers Market, by Synthesis Chemistry

  • 8.1. Introduction
  • 8.2. Liquid Phase
    • 8.2.1. Chemical Ligation
    • 8.2.2. Enzymatic Synthesis
  • 8.3. Solid Phase
    • 8.3.1. H Phosphonate Chemistry
    • 8.3.2. Phosphoramidite Chemistry

9. Column Oligonucleotide Synthesizers Market, by Throughput

  • 9.1. Introduction
  • 9.2. High Throughput
    • 9.2.1. Automated Systems
    • 9.2.2. Semi Automated Systems
  • 9.3. Low Throughput

10. Column Oligonucleotide Synthesizers Market, by Scale

  • 10.1. Introduction
  • 10.2. Long Length
  • 10.3. Medium Length
  • 10.4. Short Length

11. Column Oligonucleotide Synthesizers Market, by Application

  • 11.1. Introduction
  • 11.2. Agricultural Biotechnology
    • 11.2.1. Animal Health
    • 11.2.2. Crop Improvement
  • 11.3. Diagnostic Research
    • 11.3.1. Biomarker Assays
    • 11.3.2. Genetic Testing Kits
  • 11.4. Genomic Research
    • 11.4.1. Pcr Probes
    • 11.4.2. Sequencing Probes
  • 11.5. Therapeutic Development
    • 11.5.1. Antisense Oligonucleotides
    • 11.5.2. SiRNA Synthesis

12. Column Oligonucleotide Synthesizers Market, by End User

  • 12.1. Introduction
  • 12.2. Biopharmaceutical Companies
    • 12.2.1. Large Pharma
    • 12.2.2. Small Biotechnology Firms
  • 12.3. Contract Research Organizations
    • 12.3.1. Development Services
    • 12.3.2. Discovery Services
  • 12.4. Diagnostic Laboratories
  • 12.5. Research Institutions

13. Column Oligonucleotide Synthesizers Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Column Oligonucleotide Synthesizers Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Column Oligonucleotide Synthesizers Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Agilent Technologies, Inc.
  • 17.2. Ajinomoto Bio-Pharma Services
  • 17.3. Azenta US Inc.
  • 17.4. BioAutomation Corporation
  • 17.5. Biolytic Lab Performance Inc.
  • 17.6. Danaher Corporation
  • 17.7. Eurofins Scientific
  • 17.8. GenScript Biotech Corporation
  • 17.9. Integrated DNA Technologies
  • 17.10. Kaneka Eurogentec S.A.
  • 17.11. LGC Biosearch Technologies
  • 17.12. Merck KGaA
  • 17.13. Nitto Denko Avecia Inc.
  • 17.14. Thermo Fisher Scientific Inc.
  • 17.15. TriLink BioTechnologies LLC
  • 17.16. Twist Bioscience Corporation

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Column Oligonucleotide Synthesizers Market, Years Considered for the Study
  • FIGURE 2. Global Column Oligonucleotide Synthesizers Market, Research Design
  • FIGURE 3. Global Column Oligonucleotide Synthesizers Market, Research Framework
  • FIGURE 4. Global Column Oligonucleotide Synthesizers Market, Data Triangulation
  • FIGURE 5. Global Column Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Column Oligonucleotide Synthesizers Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Column Oligonucleotide Synthesizers Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2025 vs 2032 (%)
  • FIGURE 9. Global Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Column Oligonucleotide Synthesizers Market Size, by Throughput, 2025 vs 2032 (%)
  • FIGURE 11. Global Column Oligonucleotide Synthesizers Market Size, by Throughput, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Column Oligonucleotide Synthesizers Market Size, by Scale, 2025 vs 2032 (%)
  • FIGURE 13. Global Column Oligonucleotide Synthesizers Market Size, by Scale, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Column Oligonucleotide Synthesizers Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 15. Global Column Oligonucleotide Synthesizers Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Column Oligonucleotide Synthesizers Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 17. Global Column Oligonucleotide Synthesizers Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Column Oligonucleotide Synthesizers Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Column Oligonucleotide Synthesizers Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Column Oligonucleotide Synthesizers Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Column Oligonucleotide Synthesizers Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Column Oligonucleotide Synthesizers Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Column Oligonucleotide Synthesizers Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Column Oligonucleotide Synthesizers Market Segmentation & Coverage
  • TABLE 2. Global Column Oligonucleotide Synthesizers Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Capillary Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Capillary Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Capillary Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global HPLC Integrated Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global HPLC Integrated Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global HPLC Integrated Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Preparative Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Preparative Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Preparative Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Large Scale Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Large Scale Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Large Scale Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Medium Scale Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Medium Scale Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Medium Scale Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 23. Global Liquid Phase Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Liquid Phase Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Liquid Phase Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Chemical Ligation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Chemical Ligation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Chemical Ligation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Enzymatic Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Enzymatic Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Enzymatic Synthesis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Solid Phase Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Solid Phase Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Solid Phase Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global H Phosphonate Chemistry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global H Phosphonate Chemistry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global H Phosphonate Chemistry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Phosphoramidite Chemistry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Phosphoramidite Chemistry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Phosphoramidite Chemistry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 42. Global High Throughput Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global High Throughput Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global High Throughput Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Automated Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Automated Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Automated Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Semi Automated Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Semi Automated Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Semi Automated Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Low Throughput Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Low Throughput Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Low Throughput Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 55. Global Long Length Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Long Length Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Long Length Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Medium Length Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Medium Length Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Medium Length Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Short Length Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Short Length Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Short Length Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 65. Global Agricultural Biotechnology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Agricultural Biotechnology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Agricultural Biotechnology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Animal Health Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Animal Health Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Animal Health Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Crop Improvement Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Crop Improvement Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Crop Improvement Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Diagnostic Research Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Diagnostic Research Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Diagnostic Research Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Biomarker Assays Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Biomarker Assays Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Biomarker Assays Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Genetic Testing Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Genetic Testing Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Genetic Testing Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Genomic Research Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Genomic Research Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Genomic Research Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Pcr Probes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Pcr Probes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Pcr Probes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Sequencing Probes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Sequencing Probes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Sequencing Probes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global Therapeutic Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Therapeutic Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Therapeutic Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Antisense Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Antisense Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Antisense Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global SiRNA Synthesis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global SiRNA Synthesis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global SiRNA Synthesis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 102. Global Biopharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global Biopharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global Biopharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Small Biotechnology Firms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Small Biotechnology Firms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Small Biotechnology Firms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 114. Global Development Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 115. Global Development Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 116. Global Development Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 117. Global Discovery Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. Global Discovery Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. Global Discovery Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 120. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 122. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 123. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 124. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 125. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 126. Global Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 127. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 128. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 129. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 130. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 131. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 132. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 133. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 134. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 135. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 136. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 137. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 138. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 139. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 140. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 141. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 142. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 143. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 144. Asia-Pacific Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 145. North America Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 146. North America Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 147. North America Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 148. North America Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 149. North America Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 150. North America Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 151. North America Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 152. North America Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 153. North America Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 154. North America Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 155. North America Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 156. North America Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 157. North America Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 158. North America Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 159. North America Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 160. North America Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 161. North America Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 162. North America Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 163. Latin America Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 164. Latin America Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 165. Latin America Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 166. Latin America Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 167. Latin America Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 168. Latin America Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 169. Latin America Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 170. Latin America Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 171. Latin America Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 172. Latin America Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 173. Latin America Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 174. Latin America Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 175. Latin America Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 176. Latin America Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 177. Latin America Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 178. Latin America Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 179. Latin America Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 180. Latin America Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 181. Europe Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 182. Europe Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 183. Europe Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 184. Europe Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 185. Europe Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 186. Europe Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 187. Europe Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 188. Europe Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 189. Europe Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 190. Europe Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 191. Europe Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 192. Europe Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 193. Europe Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 194. Europe Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 195. Europe Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 196. Europe Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 197. Europe Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 198. Europe Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 199. Middle East Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 200. Middle East Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 201. Middle East Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 202. Middle East Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 203. Middle East Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 204. Middle East Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 205. Middle East Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 206. Middle East Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 207. Middle East Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 208. Middle East Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 209. Middle East Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 210. Middle East Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 211. Middle East Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 212. Middle East Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 213. Middle East Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 214. Middle East Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 215. Middle East Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 216. Middle East Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 217. Africa Column Oligonucleotide Synthesizers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 218. Africa Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 219. Africa Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 220. Africa Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 221. Africa Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 222. Africa Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 223. Africa Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 224. Africa Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 225. Africa Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 226. Africa Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 227. Africa Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 228. Africa Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 229. Africa Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 230. Africa Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 231. Africa Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 232. Africa Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Africa Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 234. Africa Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 235. Global Column Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 236. ASEAN Column Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 237. ASEAN Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 238. ASEAN Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 239. ASEAN Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 240. ASEAN Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 241. ASEAN Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 242. ASEAN Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 243. ASEAN Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 244. ASEAN Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 245. ASEAN Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 246. ASEAN Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 247. ASEAN Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 248. ASEAN Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 249. ASEAN Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 250. ASEAN Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 251. ASEAN Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. ASEAN Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 253. ASEAN Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 254. GCC Column Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 255. GCC Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 256. GCC Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 257. GCC Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 258. GCC Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 259. GCC Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 260. GCC Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 261. GCC Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 262. GCC Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 263. GCC Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 264. GCC Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 265. GCC Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 266. GCC Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 267. GCC Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 268. GCC Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 269. GCC Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 270. GCC Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 271. GCC Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 272. European Union Column Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 273. European Union Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 274. European Union Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 275. European Union Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 276. European Union Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 277. European Union Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 278. European Union Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 279. European Union Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 280. European Union Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 281. European Union Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 282. European Union Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 283. European Union Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 284. European Union Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 285. European Union Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 286. European Union Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 287. European Union Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 288. European Union Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 289. European Union Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 290. BRICS Column Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 291. BRICS Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 292. BRICS Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 293. BRICS Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 294. BRICS Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 295. BRICS Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 296. BRICS Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 297. BRICS Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 298. BRICS Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 299. BRICS Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 300. BRICS Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 301. BRICS Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 302. BRICS Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 303. BRICS Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 304. BRICS Column Oligonucleotide Synthesizers Market Size, by Therapeutic Development, 2017-2032 (USD Million)
  • TABLE 305. BRICS Column Oligonucleotide Synthesizers Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 306. BRICS Column Oligonucleotide Synthesizers Market Size, by Biopharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 307. BRICS Column Oligonucleotide Synthesizers Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 308. G7 Column Oligonucleotide Synthesizers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 309. G7 Column Oligonucleotide Synthesizers Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 310. G7 Column Oligonucleotide Synthesizers Market Size, by Analytical, 2017-2032 (USD Million)
  • TABLE 311. G7 Column Oligonucleotide Synthesizers Market Size, by Preparative, 2017-2032 (USD Million)
  • TABLE 312. G7 Column Oligonucleotide Synthesizers Market Size, by Synthesis Chemistry, 2017-2032 (USD Million)
  • TABLE 313. G7 Column Oligonucleotide Synthesizers Market Size, by Liquid Phase, 2017-2032 (USD Million)
  • TABLE 314. G7 Column Oligonucleotide Synthesizers Market Size, by Solid Phase, 2017-2032 (USD Million)
  • TABLE 315. G7 Column Oligonucleotide Synthesizers Market Size, by Throughput, 2017-2032 (USD Million)
  • TABLE 316. G7 Column Oligonucleotide Synthesizers Market Size, by High Throughput, 2017-2032 (USD Million)
  • TABLE 317. G7 Column Oligonucleotide Synthesizers Market Size, by Scale, 2017-2032 (USD Million)
  • TABLE 318. G7 Column Oligonucleotide Synthesizers Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 319. G7 Column Oligonucleotide Synthesizers Market Size, by Agricultural Biotechnology, 2017-2032 (USD Million)
  • TABLE 320. G7 Column Oligonucleotide Synthesizers Market Size, by Diagnostic Research, 2017-2032 (USD Million)
  • TABLE 321. G7 Column Oligonucleotide Synthesizers Market Size, by Genomic Research, 2017-2032 (USD Million)
  • TABLE 322. G7 Column Olig